课题基金 / 基金详情

Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort

Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
前瞻性纵向队列中不同种族和民族的育龄女性雄激素和卵巢标志物的异常
批准号:
10930196
负责人:
CATHERINE KIM
金额:
$76.13万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-23 至 2024-08-31

项目摘要

项目成果

CATHERINE KIM的其他基金

相似基金

相关文献

中文摘要
翻译
多囊卵巢综合征(PCOS)是育龄妇女和 以高雄激素血症、月经不规律和多囊卵巢肿大为特征。基因 多囊卵巢综合征的架构还包括肥胖和胰岛素抵抗,因此患有多囊卵巢综合征的女性通常有 体重指数(BMI)升高和糖耐量减低。2021年10月,美国国立卫生研究院召开了一次PCOS 研讨会;共同I西斯科维克报告了关于多囊卵巢综合征和心血管疾病(心血管疾病)的知识差距。 首先,识别异常雄激素、月经和卵巢标志物的最佳实践尚不清楚, 尤其是随着女性年龄的增长。异常值的临界点是任意的,并基于专家的意见; 血清卵巢标记物与放射学标记物相比的预测价值不被接受; 血液中雄激素的检测还不确定。其次,人们不了解PCOS的特征和 亚型因种族和民族、社会经济地位(SES)和潜在的可改变因素而不同 例如体重指数和口服避孕药(OCP)。第三,目前还不清楚多囊卵巢综合征的特征能在多大程度上预测 超过标准危险因素的心脏代谢性疾病的风险。同样,PCOS的亚型是否也是未知的 具有不同的心脏代谢性疾病风险。这些问题最好是使用基于人口的方法来解决 从生育年龄到老年的预期队列,因为这样的研究最大限度地减少了转诊和 结果的确定。然而,这样的研究很少。青年人群冠状动脉危险性的发展 成人研究(CARDIA)和达拉斯心脏研究(DHS)是两项基于人群、前瞻性、纵向的研究 在黑人和白人参与者的生育期(18-30岁)首次抽样的队列 CARDIA,35-49岁,在国土安全部),并一直跟随他们的队列到中年后期。这项研究使用了 确定月经史和外源性雌激素使用情况的相同问卷。这两项研究 有反复测量传统和新的心血管疾病风险因素的表型深刻的女性, 包括冠状动脉钙化(CAC)、心血管事件判断、 以及卵巢的放射学评估。我们的团队由这些研究的PI和精通这些研究的专家组成 在PCOS的争议中,将建立在这种丰富的基础设施上。我们将使用现有的数据和样本 来自两项研究中的育龄妇女(CARDIA中n=1163人,其中大约一半是黑人; N=827在国土安全部,大约三分之二是黑人,25%是非西班牙裔白人,10%是拉丁裔)。我们 将使用最先进的质谱仪测量包括11种氧-雄激素在内的雄激素代谢产物 抗苗勒氏激素(AMH)和性激素结合球蛋白(SHBG)。我们将应用机器学习 生成切割点和PCOS分组的策略,将它们与传统定义进行比较,并 表型,并通过种族和民族群体、SES和OCP使用来检查关联。最后,我们将检查 心脏代谢风险的前瞻性关联,特别是事件。不需要额外的数据收集。
英文摘要
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive-age women and characterized by hyperandrogenemia, irregular menses, and enlarged polycystic ovaries. The genetic architecture of PCOS also includes obesity and insulin resistance, and thus women with PCOS often have elevated body mass index (BMI) and glucose intolerance. In October 2021, the NIH convened a PCOS workshop; co-I Siscovick reported on knowledge gaps regarding PCOS and cardiovascular disease (CVD). First, best practices for identification of abnormal androgens, menses, and ovarian markers are unclear, particularly as women age. Cutpoints for abnormal values are arbitrary and based upon expert opinion; the predictive value of serum ovarian markers compared to radiographic markers is not accepted; and optimal tests for blood androgens is uncertain. Second, it is not understood how PCOS characteristics and subphenotypes differ by race and ethnicity; socioeconomic status (SES); and potentially modifiable factors such as BMI and oral contraceptive use (OCP). Third, it is unclear to what extent PCOS characteristics predict risk for cardiometabolic disease beyond standard risk factors. Similarly, it is unknown if PCOS subphenotypes confer different risks of cardiometabolic disease. These issues are best addressed using population-based prospective cohorts spanning reproductive age to older age, as such studies minimize biases in referral and ascertainment of outcomes. However, such studies are few. The Coronary Artery Risk Development in Young Adults Study (CARDIA) and the Dallas Heart Study (DHS) are two population-based, prospective, longitudinal cohorts which first sampled Black and white participants during their reproductive years (age 18-30 years in CARDIA, age 35-49 years in DHS) and have followed their cohorts to late middle age. The studies used identical questionnaires for ascertainment of menstrual history and exogenous estrogen use. Both studies have deeply phenotyped women with repeated measures of traditional and novel CVD risk factors, intermediate atherosclerotic markers including coronary artery calcification (CAC), adjudication of CVD events, and radiographic assessment of ovaries. Our team, consisting of PIs of these studies, and experts well-versed in the controversies of PCOS, will build upon this rich infrastructure. We will use existing data and samples from reproductive-age women in both studies (n=1163 in CARDIA, approximately half of whom were Black; n=827 in DHS, approximately two-thirds of whom were Black, 25% non-Hispanic white, and 10% Latina). We will measure androgenic metabolites including 11 oxy-androgens using state-of-the-art mass spectrometry and anti-Müllerian hormone (AMH) and sex hormone binding globulin (SHBG). We will apply machine learning strategies to generate cutpoints and PCOS groupings, compare these to conventional definitions and phenotypes, and examine associations by racial and ethnic group, SES, and OCP use. Finally, we will examine prospective associations with cardiometabolic risk, particularly events. No additional data collection is needed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gestational diabetes and offspring aging and metabolism
Gestational diabetes and offspring aging and metabolism
Beneficial effects of childhood vaccines for prevention of type 1 diabetes, autoimmune thyroid disease, and celiac disease
Beneficial effects of childhood vaccines for prevention of type 1 diabetes, autoimmune thyroid disease, and celiac disease
海外基金